Invitations to Industry - Karen Akinsanya, Chief Biomedical Scientist at Schrodinger
Monday, April 05, 2021, 06:00pm
via Zoom (pre-register)
Karen Akinsanya is a Chief Biomedical Scientist, with more than 20 years of hands-on experience in translational science including target selection, validation, early clinical development and business development at Merck & Co. and Ferring Pharmaceuticals. Karen is a Endocrine Physiology PhD from Imperial College London.
LinkedIn: Karen Akinsanya
For future Invitations to Industry (i2i) talks check here.